The mechanism degrades short-lived proteins that support brain and immune functions

Cell therapy engineered to eliminate established tumors, train immune system

Study in preclinical models shows aspirin may help reduce risk of cancer

Glioblastoma is a deadly cancer and notoriously resistant to treatment.

What if cancer cells could be re-engineered to turn against their own kind?

Researchers i­­­dentify Notch binding sites and their relation to leukemia cells

Daphne Haas-Kogan Named Radiation Oncology Professor at HMS